PF

Pension Fund of the Christian Church

North America, Indiana, United States, Indianapolis

Description

Pension Fund of the Christian Church is a company that specializes in pension plans.

Investor Profile

Pension Fund of the Christian Church has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Life Science, Medical.

Stage Focus

  • Series C (50%)
  • Series Unknown (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pension Fund of the Christian Church frequently co-invest with?

H.I.G. Capital
North America, Florida, United States, Miami
Co-Investments: 1
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
3B Future Health Fund
Europe, Bayern, Germany, Monaco
Co-Investments: 1
Elevate Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 1
Olympus Corporation of the Americas
North America, Pennsylvania, United States, Center Valley
Co-Investments: 1

Which angels does Pension Fund of the Christian Church often collaborate with?

Shared Deals: 1

What are some of recent deals done by Pension Fund of the Christian Church?

On Target Laboratories

Northbrook, Illinois, United States

On Target Laboratories engages in discovering, developing, and commercializing small molecules that target specific pathological

BiotechnologyLife ScienceMedical
Series CNov 16, 2023
Amount Raised: $30,000,000
On Target Laboratories

Northbrook, Illinois, United States

On Target Laboratories engages in discovering, developing, and commercializing small molecules that target specific pathological

BiotechnologyLife ScienceMedical
Series UnknownMar 11, 2014
Amount Raised: $15,000,000